With a significant increase in rabies exposures this year, Rodney Rohde, PhD, talks about seeking medical attention after animal interactions as well as clinical treatment when people have been bit or scratched.
|Videos|June 24, 2016
The Effects of Endocrine Disrupting Chemicals on Mosquito-borne Viruses
Author(s)Contagion Editorial Staff
Justin R. Anderson, PhD, associate professor of biology at Radford University, describes his research on the effects of endocrine disrupting chemicals on mosquito-borne viruses.
Advertisement
Justin R. Anderson, PhD, associate professor of biology at Radford University, describes his research on the effects of endocrine disrupting chemicals on mosquito-borne viruses, presented at ASM Microbe 2016.
Interview Transcript (slightly modified for readability)
"My research is involved in looking at ways that mosquitos transmit mosquito-borne viruses and how we can eventually block that transmission.
The research I presented today is on how contaminants in the environment affect mosquito development and potentially the replication of a mosquito-borne virus called La Crosse virus. La Crosse virus is a mosquito-borne virus that is not terribly important, but it can cause pediatric encephalitis. Maybe 70 cases a year are reported in the eastern United States, but it’s a very good model system for us to understand how viruses can replicate inside mosquitoes. We looked at exposing mosquitoes to endocrine disrupting chemicals, what effect those EDCs had on the development of the mosquito, and then in a separate experiment what the endocrine disrupters did to virus replication."
Advertisement
Related to this article
FDA-cleared single-step immunoblot tests built on recombinant antigens from multiple Borrelia species detected nearly twice as many early Lyme disease cases as standard two-tier testing. Joseph J. Burrascano Jr, MD, offers insights into what the new tests mean for clinicians.
Lori Handy, MD, provides guidance in these areas including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
Jason Pogue, PharmD, BCPS, BCIDP, contextualizes preliminary data looking at this trial and other extended-spectrum beta-lactamase (ESBL) studies, which reopens the debate around carbapenem-sparing treatment options.
Following World Rabies Day and a CDC health advisory on a 17% rise in exposure-related calls, Rodney E. Rohde, PhD, explains what the increase means, what people should do when they have an animal bite or scratch, and how clinicians should assess risk and administer post-exposure prophylaxis (PEP).
Investigators accessed longitudinal human data from ebola virus vaccination for signals of efficacy against the Bundibugyo species now surging in the Democratic Republic of Congo.
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
Advertisement
Advertisement